相关实验视频

Updated: Mar 7, 2026

Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

Published on: July 7, 2023

在现代常规白内障手术中VISIOL的现实性能和安全性

Kulawan Rojananuangnit¹, Thanapong Somkijrungroj², Teeravee Hongyok³

¹Department of Ophthalmology, Mettapracharak (Wat Rai Khing) Hospital, Nakhon Pathom, 73210, Thailand.

Ophthalmology and therapy

|March 5, 2026

概括

视力 (VISIOL) 是一种粘性适应性眼科粘性手术装置 (OVD),在白内障手术中被证明是安全有效的. 它改善了视觉敏,并保持了前腔室的稳定性,并发症最小.

科学领域:

眼科医生眼科眼科
手术设备手术设备

背景情况:

白内障手术需要眼科粘度手术装置 (OVD) 来稳定前腔和保护角膜内皮在发酵过程中.
含有氨酸和曼尼托尔的粘性适应性OVDVISIOL旨在提高外科手术的安全性并最大限度地减少内皮外伤.
对于VISIOL的性能,现有有限的当代真实世界数据存在.

研究的目的:

预期评估VISIOL在常规白内障手术中的性能和安全性.
评估VISIOL在维持前腔稳定性和保护角膜内皮中的有效性.
根据ISO 15798标准收集VISIOL的现实数据.

主要方法:

一项前性,市场推出后的临床后续研究,涉及泰国三级医院接受发酵乳化治疗的成年患者.
使用VISIOL作为外科辅助,在手术期间记录了眼内压力 (IOP) 和外科医生评估.
视角完整性,前腔炎症,IOP和最佳校正视敏度 (BCVA) 在手术前和术后90天内进行评估.

主要成果:

手术后3个月,BCVA的平均值从logMAR 0.68显著改善到0.084 (p < 0.0001).手术后3个月,BCVA的平均值从logMAR 0.68显著改善到0.084 (p < 0.0001).
内皮细胞密度在3个月后平均下降6.3% (p < 0.0001).
外科医生报告了前腔室维护的高效率 (79-99%) 和易用性 (98-99%).

结论:

在患有严重白内障的患者中,VISIOL证明了出色的安全性和有利的外科治疗结果,包括患有绿内障的患者.
该设备与最小的并发症和在化过程中有效管理前腔室有关.
VISIOL支持更安全的手术操作,并有助于在白内障手术后的视力敏度积极的结果.

关键词:

白内障是什么?白内障是什么?白内障是什么?内皮细胞密度内皮细胞密度氨酸是什么? 氨酸是什么?眼内压力眼内压力眼科粘性手术装置眼科粘性手术装置发泡乳化法可化

更多相关视频

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Published on: December 1, 2023

A Novel Capsulorhexis Technique Using Shearing Forces with Cystotome

A Novel Capsulorhexis Technique Using Shearing Forces with Cystotome

Published on: May 15, 2010

相关概念视频

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...